Acute encephalopathy with combination dabrafenib/trametinib therapy. (Record no. 25838291)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01529 a2200361 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517084734.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201807s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1477-092X |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1177/1078155216638551 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Cooper, Jalyn |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20180703 |
245 00 - TITLE STATEMENT | |
Title | Acute encephalopathy with combination dabrafenib/trametinib therapy. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners |
Date of publication, distribution, etc. | Jun 2017 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 313-317 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Case Reports; Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Acute Disease |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Brain Diseases |
General subdivision | chemically induced |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Imidazoles |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Melanoma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Oximes |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Proto-Oncogene Proteins B-raf |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyridones |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyrimidinones |
General subdivision | administration & dosage |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kodali, Dheeraj |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Higa, Gerald M |
773 0# - HOST ITEM ENTRY | |
Title | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners |
Related parts | vol. 23 |
-- | no. 4 |
-- | p. 313-317 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1177/1078155216638551">https://doi.org/10.1177/1078155216638551</a> |
Public note | Available from publisher's website |
No items available.